Kura Oncology officer plans $36.5K stock sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Kura Oncology, Inc. (KURA) officer Thomas James Doyle reported a planned sale of 4,697 shares of common stock, with an aggregate market value of $36,495.69 and an approximate sale date of November 16, 2026. The notice identifies the shares as acquired from the issuer on November 13, 2026, in a transaction designated “PSU.”
Key Figures
Key Terms
PSU technical
Performance-Based Restricted Stock Units technical
Sell-to-cover financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.